Nasdaq
$3.37▼ 0.88%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $10.8MShares out 3.2M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
11- 10.13Pre-market26.10.13 13:15filedEFFECTOther#●●●#●●●
Passage BIO, Inc.
Passage BIO, Inc.'s registration statement (Form S-3) became effective with the SEC on October 9, 2026. This effectiveness grants the company the legal authorization to proceed with various financial activities, including potential future equity offerings.…more
$3.37-0.88%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.9After-hours26.10.10 05:45424B3Offering
Passage BIO, Inc.
Passage Bio has finalized a merger agreement with Remix Therapeutics and will hold a special meeting of stockholders on November 5, 2026. Following the merger, the company will be renamed Remix Therapeutics, implement a reverse stock split at a ratio between 1-for-2 and 1-for-10, and complete a concurrent financing of approximately $100 million.…more
$3.37-0.88%vs prev closeView filingShare - 10.8After-hours26.10.09 05:57S-4/AOffering
Passage BIO, Inc.
Passage Bio has finalized a merger agreement with Remix Therapeutics and scheduled a special stockholder meeting for November 5, 2026. Upon completion, the company will be renamed Remix Therapeutics, implement a reverse stock split at a ratio between 1-for-2 and 1-for-10, and execute a concurrent financing of approximately $100 million.…more
$3.37-0.88%vs prev closeView filingShare
10 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswireNo news collected yet. New articles will appear here.